Planning and Evaluation Core

规划与评估核心

基本信息

  • 批准号:
    10328037
  • 负责人:
  • 金额:
    $ 19.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-21 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT: PLANNING AND EVALUATION CORE The Planning and Evaluation Core (PEC) will ensure that planning, monitoring, evaluation, and tracking of partnership activities will be comprehensive to the needs of the Meharry Medical College/Vanderbilt-Ingram Cancer Center/Tennessee State University Cancer Partnership (MVTCP), and utilize evaluation activities to ensure that the MVTCP is successful in contributing to the broad goals of the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) program. The information we garner through our evaluation processes will be used to guide the investment of resources into projects, programs, and institutional-level strategies such as recruitment and leveraging of resources that support the goals of the Partnership. At a time in which cancer health disparities and inequities in research and education remain as major barriers to improving health and quality-of-life for all, ensuring that the efforts of the MVTCP are successful is paramount. Conducting high-quality, continuous evaluation of the MVTCP provides the opportunity to document our efforts, measure our successes, and attend to our weaknesses for the purposes of program improvement. During the past funding cycle, the PEC worked with all cores of the MVTCP to develop logic models that are used to identify program theory, as well as the measurable outputs and outcomes of each core. The metrics identified through this process were then harmonized with the CPACHE-wide evaluation indicators to create an integrated outcome framework designed to capture the broader impact of the MVTCP. In the next funding cycle, we will build on this work to develop evaluation tools and processes to ensure high-quality implementation of funded projects, integration among projects and cores, and dissemination of methods and findings that demonstrate the impact of the MVTCP. The work of PEC will be guided by the following aims: 1) foster on-going coordination facilitated by the Administrative Core, with the Internal Advisory Committee and Program Steering Committee to ensure the MVTCP is receiving expert feedback and guidance on cores, projects, and the performance of the MVTCP as a whole; 2) use a combination of established and innovative evaluation techniques to assess the MVTCP and its accomplishment of short- and long-term goals; 3) develop a culture of evaluation within the MVTCP that is committed to the use of data to support decision making, drive quality improvement, and inform dissemination.
项目摘要/摘要:规划和评估核心 规划和评估核心(PEC)将确保规划、监控、评估和跟踪 合作伙伴活动将全面满足梅哈里医学院/范德比尔特-英格拉姆分校的需求 癌症中心/田纳西州立大学癌症合作伙伴关系 (MVTCP),并利用评估活动 确保 MVTCP 成功促进全面伙伴关系的广泛目标 推进癌症健康公平 (CPACHE) 计划。我们通过评估获得的信息 将使用流程来指导对项目、计划和机构层面的资源投资 战略,例如支持伙伴关系目标的招募和利用资源。一次 其中,癌症健康方面的差异以及研究和教育方面的不平等仍然是改善癌症健康状况的主要障碍 为了所有人的健康和生活质量,确保 MVTCP 的努力取得成功至关重要。指挥 对 MVTCP 的高质量、持续评估提供了记录我们的努力、衡量我们的成果的机会 成功,并关注我们的弱点以改进计划。在过去的融资过程中 循环中,PEC 与 MVTCP 的所有核心合作开发用于识别程序的逻辑模型 理论,以及每个核心的可衡量的产出和成果。通过此过程确定的指标 然后与 CPACHE 范围内的评估指标相协调,以创建一个综合成果框架 旨在捕捉 MVTCP 的更广泛影响。在下一个资助周期中,我们将在这项工作的基础上 开发评估工具和流程,确保资助项目的高质量实施、整合 项目和核心之间的交流,以及传播证明项目影响的方法和调查结果 MVTCP。 PEC 的工作将遵循以下目标: 1) 促进持续的协调 行政核心,设有内部咨询委员会和项目指导委员会,以确保 MVTCP 正在接收有关核心、项目和 MVTCP 性能的专家反馈和指导 所有的; 2) 结合使用已建立的和创新的评估技术来评估 MVTCP 及其 短期和长期目标的实现; 3) 在 MVTCP 中发展一种评估文化 致力于使用数据来支持决策、推动质量改进和信息传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah V Suiter其他文献

Sarah V Suiter的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah V Suiter', 18)}}的其他基金

Evaluation Core
评估核心
  • 批准号:
    10664629
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    10693365
  • 财政年份:
    2011
  • 资助金额:
    $ 19.19万
  • 项目类别:

相似海外基金

Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
项目 4:现成的工程化脐带血自然杀伤细胞,用于治疗急性淋巴细胞白血病
  • 批准号:
    10931069
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
BCM-TSU CURED Administration Core (AC)
BCM-TSU CURED 管理核心 (AC)
  • 批准号:
    10762266
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
BCM/TSU P20 Collaborative Union for Cancer Research, Education and Disparities (CURED) Administrative Core (AC)
BCM/TSU P20 癌症研究、教育和差异合作联盟 (CURED) 行政核心 (AC)
  • 批准号:
    10762046
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Therapeutic targeting of RTK protein granules in cancer
RTK 蛋白颗粒在癌症中的治疗靶向
  • 批准号:
    10591331
  • 财政年份:
    2023
  • 资助金额:
    $ 19.19万
  • 项目类别:
Oklahoma Center of Medical Imaging for Translational Cancer Research
俄克拉荷马州转化癌症研究医学影像中心
  • 批准号:
    10573264
  • 财政年份:
    2022
  • 资助金额:
    $ 19.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了